Stocktoria
Nurix Therapeutics, Inc. NRIX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-07-24
Nurix Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,820,015 | $142.3M | 6.7% |
| ARK Investment Management LLC | 1,793,196 | $43.5M | 1.76% |
| CITADEL ADVISORS LLC | 1,529,419 | $37.1M | 1.5% |
| D. E. Shaw & Co., Inc. | 184,551 | $4.5M | 0.18% |
| AQR CAPITAL MANAGEMENT LLC | 179,464 | $4.4M | 0.18% |
| Point72 Asset Management, L.P. | 73,069 | $1.8M | 0.07% |
| MILLENNIUM MANAGEMENT LLC | 20,910 | $507,277 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-11-30. Facts plus Stocktoria's own computed scores — not investment advice.